[HTML][HTML] The development of COVID-19 treatment
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused
a pandemic named coronavirus disease 2019 (COVID-19) that has become the greatest …
a pandemic named coronavirus disease 2019 (COVID-19) that has become the greatest …
Recent developments in the immunopathology of COVID‐19
There has been an important change in the clinical characteristics and immune profile of
Coronavirus disease 2019 (COVID‐19) patients during the pandemic thanks to the …
Coronavirus disease 2019 (COVID‐19) patients during the pandemic thanks to the …
[HTML][HTML] Rhinovirus-induced epithelial RIG-I inflammasome suppresses antiviral immunity and promotes inflammation in asthma and COVID-19
Rhinoviruses and allergens, such as house dust mite are major agents responsible for
asthma exacerbations. The influence of pre-existing airway inflammation on the infection …
asthma exacerbations. The influence of pre-existing airway inflammation on the infection …
[HTML][HTML] Post-COVID-19 syndrome comprehensive assessment: from clinical diagnosis to imaging and biochemical-guided diagnosis and management
The COVID-19 outbreak was first reported in 2019, causing massive morbidity and mortality.
The majority of the COVID-19 patients survived and developed Post-COVID-19 Syndrome …
The majority of the COVID-19 patients survived and developed Post-COVID-19 Syndrome …
[HTML][HTML] Effect of asthma, COPD, and ACO on COVID-19: A systematic review and meta-analysis
Y Uruma, T Manabe, Y Fujikura, M Iikura, M Hojo… - PLoS …, 2022 - journals.plos.org
Introduction The prevalence of asthma, chronic obstructive pulmonary disease (COPD), and
asthma-COPD overlap (ACO) in patients with COVID-19 varies, as well as their risks of …
asthma-COPD overlap (ACO) in patients with COVID-19 varies, as well as their risks of …
[HTML][HTML] Interferon gamma-1b for the prevention of hospital-acquired pneumonia in critically ill patients: a phase 2, placebo-controlled randomized clinical trial
Purpose We aimed to determine whether interferon gamma-1b prevents hospital-acquired
pneumonia in mechanically ventilated patients. Methods In a multicenter, placebo …
pneumonia in mechanically ventilated patients. Methods In a multicenter, placebo …
Inhaled corticosteroids for the treatment of COVID-19
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has caused
severe illness and mortality for millions worldwide. Despite the development, approval and …
severe illness and mortality for millions worldwide. Despite the development, approval and …
Multiplex hybrid antigen-capture LC-MRM quantification in sera and nasal lining fluid of AZD7442, a SARS-CoV-2-targeting antibody combination
AZD7442 (tixagevimab [AZD8895]/cilgavimab [AZD1061]) is a monoclonal antibody (mAb)
combination in development for the prevention and treatment of coronavirus disease 2019 …
combination in development for the prevention and treatment of coronavirus disease 2019 …
[HTML][HTML] Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial
Background The large number of patients worldwide infected with the SARS-CoV-2 virus
has overwhelmed health-care systems globally. The Anti-Coronavirus Therapies (ACT) …
has overwhelmed health-care systems globally. The Anti-Coronavirus Therapies (ACT) …
[HTML][HTML] Analysis of plasma proteins involved in inflammation, immune response/complement system, and blood coagulation upon admission of COVID-19 patients to …
The development of new approaches allowing for the early assessment of COVID-19 cases
that are likely to become critical and the discovery of new therapeutic targets are urgently …
that are likely to become critical and the discovery of new therapeutic targets are urgently …